Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma
Purpose: To develop and validate a radiomic signature to identify EGFR mutations in patients with advanced lung adenocarcinoma.Methods: This study involved 201 patients with advanced lung adenocarcinoma (140 in the training cohort and 61 in the validation cohort). A total of 396 features were extrac...
Main Authors: | Duo Hong, Ke Xu, Lina Zhang, Xiaoting Wan, Yan Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00028/full |
Similar Items
-
CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses
by: Dongdong Mei, et al.
Published: (2018-12-01) -
Prognostic Value of Pre-Treatment CT Radiomics and Clinical Factors for the Overall Survival of Advanced (IIIB–IV) Lung Adenocarcinoma Patients
by: Duo Hong, et al.
Published: (2021-05-01) -
Radiomic signature: a non-invasive biomarker for discriminating invasive and non-invasive cases of lung adenocarcinoma
by: Yang B, et al.
Published: (2019-08-01) -
The development and validation of a radiomic nomogram for the preoperative prediction of lung adenocarcinoma
by: Qin Liu, et al.
Published: (2020-06-01) -
Value of 18F-FDG PET/CT-Based Radiomics Nomogram to Predict Survival Outcomes and Guide Personalized Targeted Therapy in Lung Adenocarcinoma With EGFR Mutations
by: Bin Yang, et al.
Published: (2020-11-01)